ObvioHealth Teams Up with Oracle to Transform Clinical Trials
Collaboration enhances decentralized trial capabilities in clinical research.
Integration of ObvioGo with Oracle’s Solution
ObvioHealth and Oracle Health and Life Sciences have announced a significant integration of the ObvioGo platform with Oracle’s Clinical One Data Collection. This partnership is pivotal in advancing decentralized and hybrid clinical trials, showcasing a modern approach to clinical research at scale.
Expanding Capabilities for Clinical Trials
This integration enriches Oracle's product offering by incorporating ObvioGo’s advanced electronic Patient Recorded Outcomes (ePRO), electronic Consent (eConsent), and electronic Clinical Outcomes Assessment (eCOA). With this combined technology, organizations can streamline their clinical trials, reducing the need for multiple third-party tools and ensuring a coherent clinical trial experience.
Benefits of the Collaboration
According to Seema Verma, executive vice president and general manager at Oracle Health and Life Sciences, this collaboration is aligned with the goal of providing innovative solutions for sponsors looking to modernize clinical development. The integration of ObvioGo’s capabilities allows for a seamless experience that supports the growth of decentralized trials within Oracle's existing ecosystem.
Streamlined Trial Execution and Data Management
Organizations can now execute trials more efficiently, ensuring high data quality, maintaining regulatory compliance, and having operational oversight across various decentralized and hybrid study designs.
Significance for ObvioHealth
The collaboration is a notable achievement for ObvioHealth. Richard Watkins, the company’s chief revenue officer, emphasized that being part of Oracle's extensive product suite confirms ObvioGo's readiness for enterprise-scale deployment. This partnership is a validation of ObvioHealth's commitment to supporting global clinical research initiatives with cutting-edge technology.
Creating a Unified Clinical Trial Experience
By utilizing ObvioGo within Oracle's Clinical One platform, research teams can enjoy increased efficiencies from study startup through participant engagement and trial oversight. This integration ensures the maintenance of governance and regulatory processes throughout the trial lifecycle.
Improving Modern Research Practices
Ivan Jarry, CEO of ObvioHealth, highlighted how this partnership will address the ever-evolving demands of contemporary research, allowing sponsors to conduct trials with greater simplification while maintaining essential flexibility for decentralized formats.
Enhanced Innovation and Future Prospects
Every advancement from Oracle Life Sciences is specifically crafted to blend into this integrated data platform. Through advanced technologies such as Oracle Cloud Infrastructure and Oracle Life Sciences AI Application Suite, organizations in the life sciences sector can fully capitalize on the benefits of a cohesive and interoperable ecosystem.
About ObvioHealth
ObvioHealth specializes in digital solutions that facilitate the execution of decentralized, hybrid, and conventional clinical trials across a variety of therapeutic areas. The ObvioGo platform empowers sponsors, contract research organizations (CROs), and research teams to effectively design studies, oversee operations, and engage participants—all within a unified system. This holistic approach aids organizations in enhancing trial execution while ensuring data integrity and adherence to regulatory standards on a global scale.
Frequently Asked Questions
What is the significance of the collaboration between ObvioHealth and Oracle?
The collaboration aims to integrate decentralized trial capabilities within Oracle’s Clinical One Data Collection to enhance the execution and management of clinical trials.
How does the integration benefit participants in clinical trials?
It provides a more streamlined and efficient process for participant engagement, improving the overall experience during trials.
What technological solutions does ObvioGo offer?
ObvioGo provides solutions for electronic Patient Recorded Outcomes (ePRO), electronic Consent (eConsent), and electronic Clinical Outcomes Assessments (eCOA).
How does this partnership reflect on the evolution of clinical trials?
This partnership showcases a shift towards modernizing clinical trials by embracing technology that supports decentralized and hybrid methodologies.
What future innovations can we expect from this collaboration?
Future innovations will likely continue enhancing operational efficiencies, regulatory compliance, and participant engagement through unified and advanced digital solutions.
